Cover Image

Impact of Gliclazide Modified Release or Glimepiride as Add-on Therapy to Metformin on Glycemic and Oxidative Stress Parameters in Type 2 Diabetic Patients

Background: Type 2 diabetes mellitus is a condition characterized by an elevation of oxidative stress, which has been implicated in diabetic progression and its vascular complications. Aim: Assessing the impact of gliclazide modified release (MR) versus glimepiride on oxidative stress markers, glyce...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fadhel A. Shehab (Author), Ali L. Jasim2 (Author), Adel Gh. Mohammed (Author)
Format:	Book
Published:	College of Pharmacy University of Baghdad, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
by: Nareen Krishna Polavarapu, et al.
Published: (2020)

Comparative Evaluation of Vildagliptin-Metformin Versus Glimepiride-Metformin on Inflammatory Markers and Glycemic Control in Type 2 Diabetes Mellitus: A Randomized, Open-Label Study
by: Navreet Kaur, et al.
Published: (2024)

Identification of the Glimepiride and Metformin Hydrochloride Physical Interaction in Binary Systems
by: Fitrianti Darusman, et al.
Published: (2021)

PERBANDINGAN EFEKTIVITAS BIAYA TERAPI KOMBINASI OBAT METFORMIN-GLIMEPIRIDE DAN ACARBOSE-GLIMEPIRIDE DI RSUD SUMEDANG TAHUN 2021
by: Nden Ajeng Tresnawati,
Published: (2022)

Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
by: Derosa G, et al.
Published: (2017)

Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients
by: Mansour Alsharidah, et al.
Published: (2018)

Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method
by: Rasmita Patra, et al.
Published: (2021)

Effect of coating method on release of Glimepiride from porosity osmotic pump tablets (POPTs)
by: Nuha Mohammed abdulkhaleq, et al.
Published: (2020)

Effects of Metformin &/or Glimepiride on Resistin Level and Related Biochemical Markers in Type 2 Diabetes Mellitus
by: Hadeel Delman Najim, et al.
Published: (2014)

The in vitro equivalence study of polymorph-modified glimepiride tablets compared to Amaryl®
by: Fitrianti Darusman, et al.
Published: (2023)

Multivariate Chemometric Assisted Analysis of Metformin Hydrochloride, Gliclazide and Pioglitazone Hydrochloride in Bulk Drug and Dosage Forms
by: Vipin Saini, et al.
Published: (2013)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016)

Genetic analysis: therapeutic drug monitoring of metformin and glimepiride on diabetic patients' plasma including genetic polymorphism
by: Areen Ibrahim, et al.
Published: (2024)

Efek Pemberian Metformin dan Metformin+Glimepiride terhadap Kadar HbA1c pada Pasien Diabetes Mellitus Tipe 2
by: Fitri Apriliany, et al.
Published: (2022)

Sibutramine versus Metformin: assessment of anthropometric, lipid and glycemic parameters in obese and overweight high-risk patients
by: Camilo Molino Guidoni, et al.
Published: (2012)

Sibutramine versus Metformin: assessment of anthropometric, lipid and glycemic parameters in obese and overweight high-risk patients
by: Leonardo Regis Leira Pereira
Published: (2012)

Impact of Critical Material Attributes of HPMC on the Release of Gliclazide from Hydrophilic Matrix Tablets
by: Carsten Huettermann, et al.
Published: (2022)

Comparative Studies of Palmatine with Metformin and Glimepiride on the Modulation of Insulin Dependent Signaling Pathway In Vitro, In Vivo & Ex Vivo
by: Okechukwu Patrick Nwabueze, et al.
Published: (2022)

What's next after metformin? focus on sulphonylurea: add-on or combination therapy
by: Lim PC, et al.
Published: (2015)

Fabrication and Characterization of Gliclazide Nanocrystals
by: Nagaraju Ravouru, et al.
Published: (2018)

Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects
by: Ju G, et al.
Published: (2020)

Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma
by: Stanislav Bozhanov, et al.
Published: (2024)

Advanced and multifaceted stability profiling of the first-line antidiabetic drugs metformin, gliclazide and glipizide under various controlled stress conditions
by: Ahmed Gedawy, et al.
Published: (2020)

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model
by: Aurigena Antunes de ARAÚJO, et al.
Published: (2019)

Alleviation of cisplatin‐induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase‐3 activity
by: Fatemeh Taghizadeh, et al.
Published: (2021)

Simultaneous determination of atorvastatin, metformin and glimepiride in human plasma by LCâMS/MS and its application to a human pharmacokinetic study
by: Srinivasa Rao Polagani, et al.
Published: (2013)

Neuro, cardio, and reno protective activities of rosuvastatin in streptozotocin-induced type 2 diabetic rats undergoing treatment with metformin and glimepiride
by: Shailaja Rondi, et al.
Published: (2014)

Methodology of Gliclazide Detection in Biological Samples
by: Serhii I. Merzlikin, et al.

Cocrystallization of gliclazide with improved physicochemical properties
by: Shivarani Eesam, et al.
Published: (2021)

Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017)

Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017)

Formulation and characterization of orodispersible tablet of glimepiride
by: Ahmad AB Yosef Kinani, et al.
Published: (2022)

Formulation of a modified release metformin. HCl matrix tablet: influence of some hydrophilic polymers on release rate and in-vitro evaluation
by: John Rojas, et al.
Published: (2011)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
by: Sunitha Sampathi, et al.
Published: (2022)

Effect of Metformin Monotherapy and Combination Therapy with Glimepiride on Lipid Profile in Drug Naive Type-2 Diabetes Patients: A Prospective Observational Study
by: Anchit Pareek, et al.
Published: (2023)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Published: (2023)

Formulation and evaluation of fast disintegrating tablet of glimepiride
by: Arooj Khalid, et al.
Published: (2018)

Improved Transmucosal Delivery of Glimepiride via Unidirectional Release Buccal Film Loaded With Vitamin E TPGS-Based Nanocarrier
by: Tahani S. Basahih, et al.
Published: (2020)

Comparative study on efficacy of empagliflozin versus sitagliptin, as an add-on therapy to metformin in type 2 diabetic patients
by: Harsh Salankar, et al.
Published: (2024)

Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients
by: Cakirca M, et al.
Published: (2014)